Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro
- 1 October 2004
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 300 (1) , 65-71
- https://doi.org/10.1016/j.yexcr.2004.07.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Identification of the Adult Human HemangioblastStem Cells and Development, 2004
- Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.Kidney International, 2003
- Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expressionBlood, 2003
- VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cellsBlood, 2003
- Identification of the hemangioblast in postnatal lifeBlood, 2002
- VEGF and the quest for tumour angiogenesis factorsNature Reviews Cancer, 2002
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 2002
- Mechanisms of angiogenesisNature, 1997
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinasesCell, 1992